(Q44556178)

4 December 2017

title

Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion (English)

1 reference

4 December 2017

1 reference

7

Schmut O

1 reference

4 December 2017

Weger M

1

1 reference

4 December 2017

Renner W

2

1 reference

4 December 2017

Pinter O

3

1 reference

4 December 2017

Stanger O

4

1 reference

4 December 2017

Temmel W

5

1 reference

4 December 2017

Fellner P

6

1 reference

4 December 2017

Haas A

8

1 reference

4 December 2017

language of work or name

1 reference

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

17

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

731-734

1 reference

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Genetic susceptibility to venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Genetic thrombophilia in patients with retinal vascular occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Some blood plasma constituents correlate with human cataract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

7 January 2021

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

7 January 2021

Central retinal artery occlusion in a patient homozygous for factor V Leiden

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

7 January 2021

Blood coagulation parameters in retinal arterial occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700495

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6700495

1 reference

4 December 2017

1 reference